{"organizations": [], "uuid": "ea487c6a047c8802b728d591650d10e2bc4031b7", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180514.html", "section_title": "Archive News &amp; Video for Monday, 14 May 2018 | Reuters.com", "url": "https://www.reuters.com/article/products-abilify/new-jersey-state-court-creates-centralized-abilify-litigation-idUSL2N1SL07O", "country": "US", "domain_rank": 408, "title": "New Jersey state court creates centralized Abilify litigation", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.01, "site_type": "news", "published": "2018-05-14T18:49:00.000+03:00", "replies_count": 0, "uuid": "ea487c6a047c8802b728d591650d10e2bc4031b7"}, "author": "Tina Bellon", "url": "https://www.reuters.com/article/products-abilify/new-jersey-state-court-creates-centralized-abilify-litigation-idUSL2N1SL07O", "ord_in_thread": 0, "title": "New Jersey state court creates centralized Abilify litigation", "locations": [], "entities": {"persons": [{"name": "deluca", "sentiment": "none"}, {"name": "james deluca", "sentiment": "none"}, {"name": "nelson johnson", "sentiment": "none"}], "locations": [{"name": "new jersey", "sentiment": "none"}, {"name": "bergen county", "sentiment": "none"}, {"name": "atlantic county", "sentiment": "none"}], "organizations": [{"name": "new jersey’s supreme court", "sentiment": "neutral"}, {"name": "westlaw", "sentiment": "none"}, {"name": "superior court", "sentiment": "none"}, {"name": "defendants otsuka pharmaceutical inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "New Jersey’s Supreme Court has approved a request to create a multicounty litigation over antipsychotic drug Abilify, which plaintiffs allege causes compulsive behavior, adding to a growing number of centralized drug litigations in the state.\nSome 50 cases currently pending in Bergen County under Judge James DeLuca will now be centrally managed under Superior Court Judge Nelson Johnson in Atlantic County. Defendants Otsuka Pharmaceutical Inc and Bristol-Myers Squibb, who jointly developed Abilify, requested in their application for centralization that the cases remain under Judge DeLuca.\nTo read the full story on Westlaw Practitioner Insights, click here: bit.ly/2Ikn2N2\nOur Standards: The Thomson Reuters Trust Principles. 0 : 0 narrow-browser-and-phone medium-browser-and-portrait-tablet landscape-tablet medium-wide-browser wide-browser-and-larger medium-browser-and-landscape-tablet medium-wide-browser-and-larger above-phone portrait-tablet-and-above above-portrait-tablet landscape-tablet-and-above landscape-tablet-and-medium-wide-browser portrait-tablet-and-below landscape-tablet-and-below Apps Newsletters Reuters Plus Advertising Guidelines Cookies Terms of Use Privacy\nAll Quote: s delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.\n© 2018 Reuters. All Rights Reserved.", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "http://bit.ly/2Ikn2N2", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-05-14T18:49:00.000+03:00", "crawled": "2018-05-15T13:59:10.013+03:00", "highlightTitle": ""}